SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025275
Filing Date
2020-05-14
Accepted
2020-05-14 07:46:53
Documents
57
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20200331.htm 10-Q 1568146
2 EX-31.1 achv-ex311_8.htm EX-31.1 9042
3 EX-31.2 achv-ex312_9.htm EX-31.2 9078
4 EX-32.1 achv-ex321_6.htm EX-32.1 4825
5 EX-32.2 achv-ex322_7.htm EX-32.2 4850
  Complete submission text file 0001564590-20-025275.txt   5731124

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT achv-20200331.xml EX-101.INS 1069422
7 XBRL TAXONOMY EXTENSION SCHEMA achv-20200331.xsd EX-101.SCH 53841
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20200331_cal.xml EX-101.CAL 41477
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20200331_def.xml EX-101.DEF 226269
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20200331_lab.xml EX-101.LAB 408177
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20200331_pre.xml EX-101.PRE 323659
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 20875312
SIC: 2835 In Vitro & In Vivo Diagnostic Substances